Mr John Hamburger

School of Dentistry
Senior Clinical Lecturer / Honorary Consultant and Clinical Lead in Oral Medicine

Contact details

The School of Dentistry
College of Medical and Dental Sciences
University of Birmingham
St Chad's Queensway
B4 6NN
United Kingdom

John Hamburger is part-time Senior Clinical Lecturer and Honorary Consultant in Oral Medicine and is the Service and Academic Lead in this specialty.

He has published around 50 peer reviewed papers, co-authored 2 books and contributed to book chapters in the field of Oral Medicine, in particular Sjogren’s Syndrome, and Lichen Planus.

John has delivered around 200 postgraduate courses and invited lectures to various audiences.


  • FDS RCS (England) 2003.
  • FDSRCSI 1996 .
  • FFDRCSI (Oral Medicine) 1993.
  • MSc Immunology 1978.
  • BDS 1976.


John Hamburger qualified in Dentistry from the University of Birmingham in 1976 and then went on to undertake an MSc in Immunology in 1977 under Professor Philip Gell. He then joined the department of Oral Surgery and Oral Medicine at the University of Birmingham School of Dentistry, with a remit of developing the specialty of Oral Medicine. The specialty developed markedly and was subsequently split off as a separate unit in view of its activity. John finished his accreditation in London [Eastman Dental Institute and the Royal London] and was appointed to a Senior Lectureship and Honorary Consultant in 1995.

John was appointed to the Presidency of the British Society for Oral Medicine 2001-2002 and is currently a Council Member of that Society.

He has developed good collaborative links with both colleagues within his own specialty as well as in a variety of other specialties, facilitating clinical research.   John is an enthusiastic lecturer and is much in demand for delivering postgraduate lectures and courses.


Postgraduate supervision

MSc - Currently Tissue engineering.


His main research focus is that of Sjogren’s Syndrome. John has had a long collaborative link with the departments of Rheumatology and Ophthalmology and a multidisciplinary clinic serves as a platform for research into this condition, both basic and clinical. A major multicentre trial is soon to commence assessing the role of anti-B cell therapy in the management of primary Sjogren’s syndrome and he will be assessing the impact this therapy has on the salivary component of the syndrome.   Recent work on Sjogren’s has included the development of clinical activity and damage indices in Sjogren’s, tools which can assist in measuring response to therapy.  

This multidisciplinary Behcet’s disease clinic has now become a Nationally Commissioned Centre of Excellence for the management of patients with Behcet's disease.

Current portfolio collaborative research projects include The use of rituximab in the management of Sjogren's syndrome and Assessment of Electronic Salivary Flow Stimulator also for patients with Sjogren's syndrome.

Other activities

  • Council member of the British Society for Oral Medicine [previously President of the Society 2001-2002].
  • Trustee and Medical Council Member British Sjogren’s Syndrome Association 2003- current.
  • Lead on development of international guidelines for diagnosis and treatment of Oral Lichen Planus on behalf of the European Association for Oral Medicine.


Sjogren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjogren's syndrome. Bowman SJ. Sutcliffe N. Isenberg DA. Goldblatt F. Adler M. Price E. Canavan A. Hamburger J. Richards A. Rauz S. Regan M. Gadsby K. Rigby S. Jones A. Mathew R. Mulherin D. Stevenson A. Nightingale P. Rheumatology.2007 Dec 46(12):1845-51.

The Sjogren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjogren's syndrome. Barry RJ., Sutcliffe N., Isenberg DA., Price E. , Goldblatt F., Adler M,. Canavan A., Hamburger J., Richards A., Regan M., Gadsby K., Rigby S., Jones A,. Mathew R,. Mulherin D., Stevenson A., Nightingale P., Rauz S. , Bowman SJ. Rheumatology. 47(8):1193-8, 2008.

Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study.Dass, S. Bowman, S J. Vital, E M. Ikeda, K. Pease, C T. Hamburger, J. Richards, A. Rauz, S. Emery, P. Annals of the Rheumatic Diseases. 67(11):1541-4, 2008.

Patient reported outcomes in primary Sjogren’s syndrome (PSS): Comparison of the long and short versions of the profile of fatigue and discomfort – sicca symptoms inventory (PROFAD-SSI). Bowman SJ, Hamburger J, Richards A, Barry RJ, Rauz S. Rheumatology 48; 2: 140-143 ISSN: 1462-0324. 2008.

Does the use of photography help to prioritise patients when referring to the oral medicine department?.  Aslam, A. Hamburger, J.  British Dental Journal. 208(8):E16, 2010.

Estimating indirect costs in primary Sjogren's syndrome.  Bowman, Simon J. St Pierre, Yvan. Sutcliffe, Nurhan. Isenberg, David A. Goldblatt, Fiona. Price, Elizabeth. Hamburger, John. Richards, Andrea. Rauz, Saaeha. Regan, Marian. Rigby, Shirley. Jones, Adrian. Mulherin, Diarmuid. Clarke, Ann E.  Journal of Rheumatology. 37(5):1010-5, 2010.

TIRAP Ser180Leu polymorphism is associated with Behcet’s disease.  Wallace, GR, Durrani O, J Hamburger et al. Rheumatology 50 (10): 1760-5 October 2011.

The reported rates of malignant transformation of oral lichen planus. Landini G, Mylonas P, Shah IZ, Hamburger J.  J. Oral & Maxillofacial Surgery, Medicine & Pathology. (2013)